Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Complement System

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

Antibody Actions

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

Hypersensitivity Reactions: Cytolytic Reactions

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect of immunotherapy on seizure severity and spike-wave index in epileptic encephalopathy with spike-wave activation in sleep: The value of EEG spikes in monitoring treatment response.

Epilepsy research·2026

Same author

Impact of Intravenous Immunoglobulin on Neuroinflammation Markers in Patients With Electrical Status Epilepticus During Slow Sleep.

In vivo (Athens, Greece)·2026

Same author

[Increased serum transferrin receptor 1 levels are associated with severity of acute ischemic stroke in patients with Covid-19 pneumonia].

Ideggyogyaszati szemle·2026

Same author

Immune-driven mechanisms in idiopathic intracranial hypertension: a critical synthesis.

Reviews in the neurosciences·2026

Same author

NLRP3 and RANK-RANKL-OPG Pathway-related Gene Expression Levels in Children With Autism Spectrum Disorder.

In vivo (Athens, Greece)·2026

Same author

Aquaporin-1 Antibodies in Autoimmune Inflammatory Demyelinating Disorders with Predominant Optic Nerve & Spinal Cord Involvement.

Noro psikiyatri arsivi·2026

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Targeting classical complement pathway to treat complement mediated autoimmune diseases.

Erdem Tüzün¹, Jing Li, Shamsher S Saini

¹Department of Neurology, University of Istanbul, Istanbul, Turkey. drerdem@yahoo.com

Advances in Experimental Medicine and Biology

|November 26, 2008

Summary

Targeting the classical complement pathway (CCP) with anti-C1q antibodies shows promise for treating autoimmune diseases like myasthenia gravis (EAMG). This approach preserves essential immune functions while reducing disease-causing inflammation.

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

Related Experiment Videos

Last Updated: Jun 27, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

Area of Science:

Immunology
Neuroimmunology
Complement System Biology

Background:

Experimental autoimmune myasthenia gravis (EAMG) is a complement-mediated autoimmune disease.
The classical complement pathway (CCP) plays a crucial role in EAMG pathogenesis.
Mice lacking complement factor C4 are resistant to EAMG, highlighting CCP's involvement.

Purpose of the Study:

To investigate the therapeutic potential of inhibiting the classical complement pathway (CCP) in EAMG.
To evaluate the efficacy and safety of anti-C1q antibody treatment in a mouse model of EAMG.

Main Methods:

Mice were treated with anti-C1q antibodies before or after immunization with acetylcholine receptor.
Dosage and frequency of anti-C1q antibody administration were optimized (10 microg, twice weekly for 4 weeks).
Immune responses, complement deposition, and organ function were assessed in treated and control mice.

Main Results:

Anti-C1q antibody treatment suppressed EAMG development by reducing IL-6 production and immune deposits at neuromuscular junctions.
Optimal dosage (10 microg) maintained immune competence and antibody production capacity.
Higher doses of anti-C1q antibody led to adverse effects, including increased autoantibodies and kidney deposition.

Conclusions:

Classical complement pathway inhibition using anti-C1q antibodies is a viable therapeutic strategy for EAMG.
This approach preserves alternative complement pathway function, crucial for host defense.
CCP inhibition offers a potential treatment for myasthenia gravis and other complement-mediated autoimmune diseases.